Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
Classificação em ações
#4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Preço da ação
$3.89
Valor de mercado
$3.30B
Variação (1 dia)
-3.14%
Variação (1 ano)
43.11%
País
CN
Negociar Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Categoria
Healthcare
Lucros da Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Lucros em Jun 2026 TTM: $30.61M
De acordo com os últimos relatórios financeiros da Guangdong Zhongsheng Pharmaceutical Co., Ltd., os ganhos atuais da empresa são de $30.61M. Em 2024, a empresa teve ganhos de $-46.02M, uma diminuição em relação a aos ganhos de 2023, que foram de $40.07M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Guangdong Zhongsheng Pharmaceutical Co., Ltd. de 2006 a 2026
Lucros no final de cada ano
| Ano | Lucros | Alterar |
|---|---|---|
| 2026 (TTM) | $30.61M | -27.78% |
| 2025 | $42.39M | -192.12% |
| 2024 | $-46.02M | -214.83% |
| 2023 | $40.07M | -24.95% |
| 2022 | $53.39M | 9.66% |
| 2021 | $48.69M | -192.13% |
| 2020 | $-52.85M | -197.14% |
| 2019 | $54.41M | -25.14% |
| 2018 | $72.68M | -3.83% |
| 2017 | $75.58M | 8.55% |
| 2016 | $69.62M | 32.24% |
| 2015 | $52.65M | 31.36% |
| 2014 | $40.08M | 11.54% |
| 2013 | $35.94M | 5.30% |
| 2012 | $34.13M | 22.83% |
| 2011 | $27.78M | 19.74% |
| 2010 | $23.20M | 38.06% |
| 2009 | $16.81M | 34.21% |
| 2008 | $12.52M | 76.32% |
| 2007 | $7.10M | 52.00% |
| 2006 | $4.67M | 0.00% |
Lucros de empresas semelhantes ou concorrentes
| Empresa | Lucros | Diferença de Lucros | País |
|---|---|---|---|
| $3.62B | 11,717.83% |
DE
|
|
| $3.40B | 11,022.45% |
DE
|
|
| $1.72B | 5,530.23% |
JP
|
|
| $930.30M | 2,938.85% |
CH
|
|
| $1.69B | 5,429.10% |
IN
|
